124153 -

The article details recent breakthroughs in "linker" technology and more effective payloads that have led to a surge in FDA-approved treatments for breast, lung, and blood cancers.

Antibody–Drug Conjugates: The Past, Present and Future Source: Annual Review of Cancer Biology (DOI: 10.1146/annurev-cancerbio-070824-124153) 124153

Trust spillovers among national and European institutions Source: Erasmus University Rotterdam (Article ID: 124153) Researchers are now focusing on overcoming drug resistance

An older but frequently cited article in Neuroendocrinology titled "Progesterone and the Control of Functional Luteolysis" is indexed under the ID 124153 . It discusses the role of hormones in reproductive cycles. 124153

Researchers are now focusing on overcoming drug resistance and expanding ADCs beyond oncology to treat autoimmune and infectious diseases. 2. Political Science: Trust in European Institutions

Early challenges included drug instability and low potency, leading to many failed clinical trials in the late 20th century.